Therapy development
Treeway develops therapies for ALS, Alzheimer's disease and other neurodegenerative diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Treeway is a clinical-stage biotech company developing therapies for ALS, Alzheimer's disease and other neurodegenerative diseases.
The company is developing therapies for ALS, Alzheimer's disease and other neurodegenerative diseases. Treeway anticipates that patients will become essential participants in the pursuit of cures for rare and common diseases.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Treeway develops therapies for ALS, Alzheimer's disease and other neurodegenerative diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 6, 2026, September 15, 2026 and September 16, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.